Dr. Ravi Kant, is a Post-Doctoral Research Fellow at The School of Clinical & Experiemntal Sciences, Faculty of Meddine, University Hospital Southampton, University of Southampton, England.
Along with research, Dr. Ravi Kant is also actively engaged in fostering academic-industry collaborations between universities and resaerch based industries.
As a Computational Biologist, his main research interests focus on identifying novel drug targets, deciphering their mechanism of action and identifying the novel small molecule inhibitors to design & develop therapeutic drug and vaccine candidates.
More specifically, his main research responsibility is to use different aspects of Drug Discovery pipeline (Homology modeling, Pharmacophore generation, Molecular Docking and MD simulations) to identify and design lead molecules for Computer Aided Drug Designing for sexually transmitted infections, various kind of infectious diseases and targeting diverse set of pathogens.
The ongoing research projects have secured funding from some of the prime funding agencies in India (Indian Council of Medical Research, Department of Biotechnology,Government of India) & UK (BBSRC-UKRI International Partnership Funding from UK).
The current research project involves the application of artificial intelligence and machine learning based tools to identify and characterize potential vaccine candidtes form a specific pathogen of interest.
